Focused on ophthalmic therapies, the company develops and commercializes treatments for eye diseases, particularly glaucoma and other conditions linked to elevated intraocular pressure. Its portfolio has included prescription drugs such as Rhopressa and Rocklatan, aimed at lowering eye pressure in p...
No congressional trades have been disclosed for Aerie Pharmaceuticals (AERI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.